New England Biolabs Launches Integrated Indexing Primer Module for Streamlined Influenza A Sequencing on Oxford Nanopore Technologies Platforms

Streamlined, high-throughput sequencing of Influenza A virus with integrated indexing for Oxford Nanopore Technologies® platforms New England Biolab...

November 14, 2025 | Friday | News
Callan JMB Enters Agreement to Host Oral Drug Delivery Manufacturing at Texas cGMP Facility

Callan JMB INC. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), an integrative logistics company empowering the healthcare indust...

November 14, 2025 | Friday | News
Vascarta and CUNY Report Preclinical Breakthrough Demonstrating STO-1 Selectively Eliminates Glioblastoma Cells

Vascarta Inc., a healthspan focused, clinical stage biopharmaceutical company advancing safe, patient friendly therapies for pain, inflammation, and, in ...

November 11, 2025 | Tuesday | News
Facet Life Sciences and XCancer Form Strategic Partnership to Accelerate Development of Theranostic Radiopharmaceuticals

Facet Life Sciences, a leader in regulatory strategy and drug development services, announced a strategic partnership with XCancer®, a global leader ...

November 07, 2025 | Friday | News
Aceso and Samsung Partner to Advance Digital Transformation in Hospital Communication and Patient Care

-Aceso Interactive, Inc., a leading provider of patient engagement and healthcare communication technology, is pleased to announce a strategic partnershi...

November 07, 2025 | Friday | News
Eli Lilly to Invest $3 Billion in New European Manufacturing Facility at Leiden Bio Science Park, Netherlands

Netherlands site will bring 500 manufacturing and 1,500 construction jobs while further strengthening Lilly's global supply chain Eli Lilly and Company ...

November 04, 2025 | Tuesday | News
INOVIO Completes BLA Submission for INO-3107, a DNA Immunotherapy for Recurrent Respiratory Papillomatosis

Recurrent respiratory papillomatosis (RRP) is a rare HPV-related disease of the respiratory tract with significant unmet need INO-3107 previously rece...

November 04, 2025 | Tuesday | News
Pillar Biosciences and Hamilton Debut Automated Workflow for Rapid MPN NGS Testing on Microlab STAR

Pillar Biosciences, Inc., and Hamilton Company  announced the validation and release of their first automated NGS library preparation method under t...

October 31, 2025 | Friday | News
Zag Bio Launches with $80 Million Financing to Pioneer Thymus-Targeted Therapies for Autoimmune Diseases

Discovery and development of the first systemic therapeutics to deliver self-antigens directly to the thymus to harness the body’s natural mechanis...

October 29, 2025 | Wednesday | News
Jupiter Neurosciences Secures Up to $20 Million in Flexible Financing from Yorkville Advisors to Advance Parkinson’s Trial and Nugevia™ Expansion

Financing designed to support Phase 2 Parkinson’s trial and accelerate Nugevia™ product line growth Jupiter Neurosciences, Inc , a clinical...

October 28, 2025 | Tuesday | News
Bayer Receives FDA Approval for Lynkuet, the First Dual Neurokinin Therapy for Moderate to Severe Menopausal Hot Flashes

This approval is supported by data from the Phase III OASIS clinical trial program evaluating Lynkuet for the treatment of moderate to severe hot fla...

October 27, 2025 | Monday | News
Adcytherix Raises €105 Million Series A to Advance Next-Generation Antibody–Drug Conjugates with Novel Payloads

Adcytherix Raises EUR 105M Series A to Accelerate Breakthrough Antibody-Drug Conjugate Pipeline with Strategic Focus on Novel Payloads Financing led b...

October 20, 2025 | Monday | News
Azurity Pharmaceuticals Receives FDA Approval for Ferabright™, the First Iron-Based MRI Contrast Agent for Brain Tumour Imaging

Azurity Pharmaceuticals, Inc. announced that the U.S. Food and Drug Administration (FDA) has approved FerabrightTM (ferumoxytol injection), the first and...

October 20, 2025 | Monday | News
Thermo Fisher Launches SwiftArrayStudio™ Microarray Analyzer to Transform Genetic Research and Precision Medicine

Thermo Fisher Scientific, the world leader in serving science, has introduced the Applied Biosystems™ SwiftArrayStudio™ Microarray Analyzer, ...

October 17, 2025 | Friday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close